NCT04571567 2022-04-11A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque PsoriasisIcahn School of Medicine at Mount SinaiPhase 4 Completed20 enrolled